Notice of Registration - 2010
FR Doc 2010-15530[Federal Register: June 28, 2010 (Volume 75, Number 123)]
[Notices]
[Page 36694-36695]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28jn10-110]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated March 16, 2010, and published in the Federal
Register on March 24, 2010 (75 FR 14186), Roche Diagnostics Operations
Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis,
Indiana 46250, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as an importer of the basic
classes of controlled substances listed in schedules I and II:
| Drug |
Schedule |
| Lysergic acid diethylamide (7315) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Alphamethadol (9605) |
I |
| Cocaine (9041) |
II |
| Ecgonine (9180) |
II |
| Methadone (9250) |
II |
| Morphine (9300) |
II |
The company plans to import the listed controlled substances for
the manufacture of diagnostic products for distribution to its
customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the
registration of Roche Diagnostics Operations Inc. to
[[Page 36695]]
import the basic classes of controlled substances is consistent with
the public interest, and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971, at this time. DEA has investigated Roche Diagnostics Operations
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company
is granted registration as an importer of the basic classes of
controlled substances listed.
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-15530 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |